Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
NCT00328965 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2010-08-16
Summary
This study was designed to evaluate the anti-hypertensive efficacy of lacidipine in hypertensives with Type 2 diabetes and effectiveness on endothelial cell function in Korean population.
Conditions
- Diabetes Mellitus, Type 2
- Essential Hypertension
Interventions
- DRUG
-
Lacidipine
Lacidipine 2, 4, 6mg
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials, M.D., PH.D. · GlaxoSmithKline
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 35 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-11-30
- Primary Completion
- 2006-05-31
- Completion
- 2006-05-31
More Related Trials
-
Resistant Hypertension in Patients With Type-II-Diabetes Mellitus
NCT01056367 ·Status: COMPLETED
-
Developement of Questionnaire to Evaluate a Regularity of Lifestyle in Type 2 Diabetic Patients
NCT00455988 ·Status: UNKNOWN
-
Collaborative Care Model on Type 2 Diabetic Patients
NCT03553862 ·Status: COMPLETED ·Phase: NA
-
Changes in the Retinal and Carotid Microcirculation After Restoring Normoglycemia in Patients With Type 2 Diabetes
NCT03594591 ·Status: UNKNOWN
-
Personalized Medicine for Diabetes Prediction and Prevention of Complications
NCT01268813 ·Status: UNKNOWN ·Phase: PHASE1
-
Korea National Diabetes Program
NCT01212198 ·Status: UNKNOWN
-
Blood Pressure Control for Type 2 Diabetes
NCT03477786 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate the Effect of the Smart Care-diabetes Management System on Subjects With Diabetes
NCT01505036 ·Status: COMPLETED ·Phase: NA
-
Ischemic Preconditioning and Type 2 Diabetes
NCT03598855 ·Status: COMPLETED ·Phase: NA
-
Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease
NCT03578991 ·Status: COMPLETED ·Phase: NA
-
Carotid Body Function in Type 2 Diabetes Mellitus
NCT05237076 ·Status: COMPLETED ·Phase: NA
-
SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study
NCT05770687 ·Status: RECRUITING
-
LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes
NCT05313529 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cardiac Function and Microcirculation: Type 2 DIABetes and ECHOcardiographic Changes Over Time
NCT02956577 ·Status: COMPLETED
-
Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities
NCT05369065 ·Status: RECRUITING ·Phase: PHASE1
-
YJP-14 Capsules for the Treatment of Endothelial Dysfunction in Patients With Diabetes Mellitus
NCT01836172 ·Status: UNKNOWN ·Phase: PHASE2
-
Arginase Inhibition and Microvascular Endothelial Function in Type 2 Diabetes
NCT02687152 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan
NCT03084965 ·Status: COMPLETED
-
A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Singapore
NCT00836030 ·Status: COMPLETED
-
SGLT2 Inhibitor Use After Acute Myocardial Infarction in Patients With Type 2 Diabetes: A Nationwide Cohort Study
NCT07198191 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients
NCT02500329 ·Status: UNKNOWN ·Phase: PHASE4
-
Does Screening of Coronary Artery Disease an Efficient Public Health Strategy in Patients With Type 2 DIABetes
NCT04534530 ·Status: ACTIVE_NOT_RECRUITING
-
A Prospective Study on Diabetes Management Through an Integrated Delivery System
NCT00288678 ·Status: COMPLETED ·Phase: PHASE3
-
Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease
NCT01422421 ·Status: COMPLETED ·Phase: PHASE4
-
Incretin Based Therapy for Poorly Controlled Type 2 Diabetic Patients
NCT02026024 ·Status: COMPLETED